Innovations in Multiple Myeloma Treatment

Interview with Ann McNeill, RN, MSN, APN: Bispecific T-Cell Engager Therapy Considerations and Collaboration

Interview with Ann McNeill, RN, MSN, APN: Bispecific T-Cell Engager Therapy Administration and Management

Welcome to the Multiple Myeloma Resource Center! Here you’ll find current information, news items, highlights from the literature, and other resources that focus on multiple myeloma and the advanced practitioner’s role in delivering high-quality care to our patients. We’re excited to provide this information to you and your colleagues and hope this site is helpful to your practice. If you have any feedback or questions, please contact jadpro-editor@conexiant.com.


Charise Gleason, MSN, NP-C, AOCNP Winship Cancer Institute of Emory University Nell Hodgson Woodruff School of Nursing at Emory Healthcare	Amy Pierre, MSN, RN, ANP-BC Memorial Sloan Kettering Cancer Center Myeloma/Lymphoma Division Flatiron Health Real World Evidence Research Oncology

Make it Happen: To Better Serve the Multiple Myeloma Community

International Myeloma Working Group Updated Criteria for the Diagnosis of Multiple Myeloma

Ethical Challenges in CAR-T Slot Allocation

Best Practices in Expanding Access to Bispecific Antibodies and Adverse Event Management

A Focus on Relapsed Multiple Myeloma

Journal of Clinical Oncology

Isatuximab subcutaneous by on-body delivery system vs isatuximab intravenous plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Phase 3 IRAKLIA study

Current Obesity Reports

Unraveling obesity and multiple myeloma: Insights from epidemiology and molecular mechanisms

Blood and Lymphatic Cancer

An updated indirect comparison of elranatamab versus a real-world external control arm in triple-class refractory multiple myeloma

The New England Journal of Medicine

Daratumumab or active monitoring for high-risk smoldering multiple myeloma

Targeted Oncology

Teclistamab dosing in responders: Modeling and simulation results from the MajesTEC-1 study in relapsed/refractory multiple myeloma

Patient Preference and Adherence

Perspectives of healthcare providers and patients with relapsed/refractory multiple myeloma on treatment priorities and novel therapies

Bone Marrow Transplantation

Attitudes and perspectives of oncologists about measurable residual disease testing in multiple myeloma: Initiative for standardizing guidelines

Blood Cancer Journal

Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: A multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium

Cancer Reports

Efficacy and safety of quadruplet therapy in newly diagnosed transplant-eligible multiple myeloma: A systematic review and meta-analysis

Clinical Lymphoma, Myeloma & Leukemia

Expert perspectives on current challenges and emerging approaches for multiple myeloma: Narrative review of an inaugural bridging the gaps in leukemia, lymphoma, and multiple myeloma

Multiple Myeloma Resource Center